Nathan A. Beaver

ID: 1b83f0dc-2619-30fb-68c4

/

Unclaimed

/

Organization: Foley & Lardner LLP

COVID-19 Related Medical Devices: FDA Finalizes Transition Plan Guidance

Health Care Law Today · April 4, 2023

Foley & Lardner Comment Letter on DEA Telemedicine Controlled Substance Proposed Rule

Health Care Law Today · March 30, 2023

Health Care & Life Sciences Sector Top Trends for 2023

Health Care Law Today · March 1, 2023

Join Us at the American Telemedicine Association ATA2023 Annual Conference & Expo

Health Care Law Today · February 3, 2023

Modernization of Cosmetics Regulation Act of 2022: What You Need to Know

Health Care Law Today · January 25, 2023